Pharma Penny Stocks Under Rs 100 English

Pharma Penny Stocks Under Rs 100

The table below shows Pharma Penny Stocks Under Rs 100 based on the Highest Market Capitalization.

NameMarket Cap (Cr)Close Price
Alembic Ltd2402.1993.55
Morepen Laboratories Ltd2359.0446.15
Syncom Formulations (India) Ltd1193.8012.70
Nectar Lifesciences Ltd765.8534.15
ZIM Laboratories Ltd474.5995.80
Medico Remedies Ltd401.6448.40
Gennex Laboratories Ltd365.7216.05
Ambalal Sarabhai Enterprises Ltd365.5247.61
Syschem (India) Ltd251.0462.86
Kimia Biosciences Ltd245.6751.83

Content:

What Are Pharma Penny Stocks?

Pharma penny stocks in the Indian stock market are shares of small pharmaceutical companies priced below Rs 10. These stocks are highly speculative and involve significant risk due to their low market capitalization and potential for high volatility.

Investing in these stocks can be enticing due to the potential for substantial returns if a company succeeds in breakthrough developments or regulatory approvals. However, the risk of losing the entire investment is also considerably higher compared to more stable stocks.

Investors interested in pharma penny stocks should perform extensive due diligence, focusing on the company’s drug pipeline, market potential, and financial health. Understanding regulatory environments and market dynamics within India is crucial for assessing these investments.

Invest in Direct Mutual Funds IPOs Bonds and Equity at ZERO COST

Top 10 Pharma Penny Stocks Under Rs 100

The table below shows the Top 10 Pharma Penny Stocks Under Rs 100 based on 1 Year Return. 

Name1Y ReturnClose Price
Pharmaids Pharmaceuticals Ltd204.6062.96
Gennex Laboratories Ltd166.6116.05
Ind Swift Ltd153.5523.20
Ambalal Sarabhai Enterprises Ltd117.2047.61
Syncom Formulations (India) Ltd104.8412.70
Nectar Lifesciences Ltd96.2634.15
Aarey Drugs and Pharmaceuticals Ltd75.7047.35
Morepen Laboratories Ltd68.1246.15
Biofil Chemicals and Pharmaceuticals Ltd55.9668.70
Alembic Ltd55.0193.55

Pharma Penny Stocks Under Rs 100 In India

The table below shows Pharma Penny Stocks Under Rs 100 In India based on 1 Month Return. 

Name1M ReturnClose Price
Ind Swift Ltd24.6823.20
Aarey Drugs and Pharmaceuticals Ltd19.8747.35
MediCaps Ltd18.1854.13
Pharmaids Pharmaceuticals Ltd12.5862.96
Alembic Ltd11.2993.55
Syschem (India) Ltd10.4162.86
Biofil Chemicals and Pharmaceuticals Ltd9.8268.70
Sunil Healthcare Ltd8.1460.05
Bharat Immunologicals and Biologicals Corporation Ltd7.8629.81
Bal Pharma Ltd6.6098.35

Best Pharma Penny Stocks Under Rs 100

The table below shows the Best Pharma Penny Stocks Under Rs 100 based on the highest day Volume.

NameDaily VolumeClose Price
Morepen Laboratories Ltd5527973.0046.15
Syncom Formulations (India) Ltd948990.0012.70
Gennex Laboratories Ltd599730.0016.05
Alembic Ltd515120.0093.55
Medico Remedies Ltd466933.0048.40
Yash Optics & Lens Ltd340800.0088.95
Nectar Lifesciences Ltd324676.0034.15
Biofil Chemicals and Pharmaceuticals Ltd118690.0068.70
ZIM Laboratories Ltd89026.0095.80
Ind Swift Ltd87809.0023.20

List Of Best Pharma Penny Stocks Under Rs. 100

The table below shows a List Of The Best Pharma Penny Stocks Under Rs. 100 based on PE Ratio.

NamePE RatioClose Price
Nectar Lifesciences Ltd96.0434.15
Syncom Formulations (India) Ltd72.6212.70
Syschem (India) Ltd72.0762.86
Medico Remedies Ltd54.2348.40
ZIM Laboratories Ltd36.9795.80
Aarey Drugs and Pharmaceuticals Ltd34.7147.35
Morepen Laboratories Ltd33.9546.15
Alembic Ltd31.3193.55
Gennex Laboratories Ltd29.6316.05
Cian Healthcare Ltd26.7521.79

Who Should Invest In Pharma Penny Stocks Under Rs 100?

Investors who should consider pharma penny stocks under Rs 100 are those with high-risk tolerance, speculative investment strategies, and a thorough understanding of the pharmaceutical industry. Such investors must be prepared for significant volatility and the potential for both high returns and substantial losses.

How To Invest In The Pharma Penny Stocks Under Rs 100?

To invest in pharma penny stocks under Rs 100, research and select potential companies with promising pipelines or technologies. Use a reliable broker to buy shares, diversify your portfolio to mitigate risk, and stay updated on pharmaceutical industry news and regulatory changes affecting these stocks.

Performance Metrics Of Pharma Penny Stocks Under Rs 100

The performance metrics of pharma penny stocks under Rs 100 can be highly volatile, reflecting the speculative nature of these investments. Key indicators include share price fluctuations, trading volume, and financial health metrics such as earnings per share and revenue growth.

Investors should also consider the success rates of clinical trials, FDA approvals, and partnership developments as performance indicators. These metrics provide insights into a company’s potential to succeed in the competitive pharmaceutical market, impacting stock performance significantly.

Benefits Of Investing In Pharma Penny Stocks Under Rs 100

The main benefit of investing in pharma penny stocks under Rs 100 is the potential for high returns. These stocks often represent small companies that can experience significant growth if they achieve breakthroughs or gain regulatory approvals.

  • High Return Potential: Pharma penny stocks can yield substantial profits if the company successfully brings a new drug to market or partners with larger pharmaceutical firms. Such events can dramatically increase a stock’s value overnight.
  • Low Entry Cost: With shares priced under Rs 100, these stocks allow investors to buy a larger quantity of shares with a smaller initial investment, potentially maximizing gains if the stock value increases.
  • Market Movements: These stocks are sensitive to market news and regulatory events, offering opportunities for quick gains from market reactions to positive news such as successful drug trials or government approvals.
  • Diversification: Adding pharma penny stocks to a diversified investment portfolio can provide a balance to more stable investments. It introduces a higher-risk, higher-reward component that could yield returns uncorrelated with the broader market.
  • Innovative Exposure: Investing in these stocks offers exposure to innovative medical research and potential breakthrough treatments that could revolutionize health care and generate significant financial returns if successful.

Challenges Of Investing In Pharma Penny Stocks Under Rs 100

The main challenges of investing in pharma penny stocks under Rs 100 include high volatility, limited liquidity, and significant regulatory risks. Additionally, these stocks often suffer from a lack of information and a higher potential for fraud, making them risky investments.

  • High Volatility: Pharma penny stocks under Rs 100 are extremely volatile. Their prices can swing wildly based on news or market sentiment, making them unpredictable and increasing the risk of substantial losses for investors not prepared for such fluctuations.
  • Limited Liquidity: These stocks often have lower trading volumes, which can make it difficult to buy or sell large quantities without affecting the stock price. This lack of liquidity can be a significant barrier when trying to exit positions at favorable prices.
  • Regulatory Risks: The pharmaceutical industry is heavily regulated. Delays in drug approval processes or negative results from clinical trials can severely impact the stock’s value. Investors must be mindful of the regulatory environment and its potential effects.
  • Lack of Information: Small pharmaceutical companies under Rs 100 often lack the visibility of larger companies. This scarcity of information can make it challenging for investors to perform thorough due diligence, assess the company’s potential, and make informed investment decisions.
  • Fraud and Mismanagement Risk: The lower levels of scrutiny and oversight in smaller, less-regulated companies can lead to higher risks of fraud or mismanagement. Investors may face challenges in verifying the authenticity of the company’s claims and the integrity of its management.

Introduction To Pharma Penny Stocks Under Rs 100

Pharma Penny Stocks Under Rs 100 – Highest Market Capitalization.

Alembic Ltd

The market cap of Alembic Ltd stands at Rs. 2402.19 crore. The monthly return is 11.29%, while the one-year return is 55.01%. Currently, the stock is 15.07% away from its 52-week high.

Alembic Ltd is a prominent Indian pharmaceutical company, specializing in the development and manufacture of generic medicines and active pharmaceutical ingredients (APIs). Established over a century ago, it has been a pioneer in the healthcare industry, consistently providing high-quality products.

The company has a strong focus on research and innovation, ensuring it stays at the forefront of technology and market trends. With a global presence, Alembic Ltd continues to expand its reach, aiming to improve health outcomes worldwide through its extensive product portfolio.

Morepen Laboratories Ltd

The market cap of Morepen Laboratories Ltd amounts to Rs. 2359.04 crore. Its monthly return stands at 3.62%, while the one-year return reaches 68.12%. Currently, the stock is 22.21% away from its 52-week high

.

Morepen Laboratories Ltd is a well-established pharmaceutical company in India, known for its significant contributions to the wellness and health sector. The company excels in producing high-quality diagnostic products, generic drugs, and APIs.

Focused on innovation and quality, Morepen Laboratories invests heavily in research and development to stay ahead in the competitive market. Their commitment to healthcare excellence has led them to be a trusted name in both domestic and international markets.

Syncom Formulations (India) Ltd

The market cap of Syncom Formulations (India) Ltd is Rs. 1193.80 crore. The monthly return is -1.99%, while the one-year return stands at 104.84%. Presently, the stock is 46.85% away from its 52-week high.

Syncom Formulations (India) Ltd is an emerging player in the pharmaceutical industry, focusing on the manufacture and export of a wide range of medicinal products. It caters to various therapeutic segments, providing affordable healthcare solutions globally.

The company is committed to quality and innovation, with state-of-the-art manufacturing facilities that meet stringent international standards. Syncom’s strategic approach to market expansion and customer satisfaction has fueled its growth in the competitive pharmaceutical landscape.

Top 10 Pharma Penny Stocks Under Rs 100 – 1 Year Return

Pharmaids Pharmaceuticals Ltd

The market cap of Syncom Formulations (India) Ltd is Rs. 141.36 crore. The monthly return is 12.58%, while the one-year return stands at 204.60%. Presently, the stock is 25.84% away from its 52-week high.

Pharmaids Pharmaceuticals Ltd specializes in the production and distribution of a diverse range of pharmaceutical formulations. Known for its dedication to quality, the company strives to provide effective and affordable healthcare solutions to communities across India.

With a strong emphasis on compliance and ethical practices, Pharmaids Pharmaceuticals continually invests in research and development. This focus ensures the delivery of innovative products that meet the evolving needs of the healthcare sector.

Gennex Laboratories Ltd

The market cap of Gennex Laboratories Ltd stands at Rs. 365.72 crore. Its monthly return is -7.13%, while the one-year return is 166.61%. Currently, the stock is 36.39% away from its 52-week high.

Gennex Laboratories Ltd is a leading pharmaceutical company dedicated to developing innovative solutions for healthcare challenges. With a focus on research and development, Gennex aims to create high-quality, affordable medicines that improve patient outcomes and enhance quality of life.

Through state-of-the-art facilities and a team of skilled scientists, Gennex Laboratories Ltd conducts extensive research to identify novel drug targets and formulations. By collaborating with healthcare professionals and leveraging cutting-edge technology, Gennex strives to revolutionize the pharmaceutical industry and make a positive impact on global health.

Ind Swift Ltd

The market cap of Ind Swift Ltd amounts to Rs. 125.66 crore. Its monthly return stands at 24.68%, while the one-year return is 153.55%. Currently, the stock is 34.48% away from its 52-week high.

Ind Swift Ltd is a renowned pharmaceutical company that specializes in the manufacture and distribution of high-quality generic medicines. With a strong presence in both domestic and international markets, Ind Swift Ltd has established itself as a reliable name in the healthcare industry.

Committed to innovation and excellence, Ind Swift Ltd invests heavily in research and development to create affordable and effective pharmaceutical products. By adhering to stringent quality control standards and leveraging advanced manufacturing technologies, Ind Swift Ltd ensures the consistent delivery of safe and efficacious medicines to patients worldwide.

Pharma Penny Stocks Under Rs 100 In India – 1 Month Return

Aarey Drugs and Pharmaceuticals Ltd

The market cap of Aarey Drugs and Pharmaceuticals Ltd is Rs. 132.84 crore. Its monthly return is 19.87%, while the one-year return stands at 75.70%. Presently, the stock is 43.61% away from its 52-week high.

Aarey Drugs and Pharmaceuticals Ltd is known for its robust production of pharmaceutical intermediates and chemicals. The company plays a crucial role in the pharmaceutical supply chain, providing key ingredients for various therapeutic categories.

Driven by a commitment to innovation and quality, Aarey Drugs and Pharmaceuticals maintains high standards in its manufacturing processes. This dedication ensures the reliability and safety of its products, contributing significantly to the global pharmaceutical industry.

MediCaps Ltd

The market cap of MediCaps Ltd is Rs. 67.62 crore. Its monthly return is 18.18%, while the one-year return is 41.74%. Currently, the stock is 17.29% away from its 52-week high.

MediCaps Ltd is a key player in the pharmaceutical capsule market, specializing in the production of hard gelatin capsules. The company has built a reputation for delivering high-quality products that are essential for pharmaceutical formulations.

With a focus on technological advancements and quality control, MediCaps Ltd continually enhances its production capabilities. This commitment to excellence helps them meet the stringent requirements of the healthcare industry, ensuring patient safety and efficacy of medications.

Syschem (India) Ltd

The market cap of Syschem (India) Ltd is Rs. 251.04 crore. Its monthly return stands at 10.41%, while the one-year return is 54.47%. Presently, the stock is 17.56% away from its 52-week high.

Syschem (India) Ltd is an established entity in the pharmaceutical sector, known for its production of bulk drugs and intermediates. The company focuses on creating high-purity substances that are crucial for various medical treatments.

Emphasizing sustainability and innovation, Syschem (India) Ltd incorporates advanced technologies and environmental practices in its operations. This approach not only enhances their product quality but also supports the global demand for eco-friendly pharmaceutical manufacturing.

Best Pharma Penny Stocks Under Rs 100 – Highest Day Volume

Medico Remedies Ltd

The market cap of Medico Remedies Ltd stands at Rs. 401.64 crore. Its monthly return is -41.02%, while the one-year return is -40.21%. Currently, the stock is 108.06% away from its 52-week high.

Medico Remedies Ltd specializes in the manufacture and export of pharmaceutical formulations, including antibiotics and antifungals. They serve a global market, providing high-quality medicines that are essential for treating a variety of ailments.

The company is committed to upholding stringent quality standards and regulatory compliance in all its processes. This dedication ensures the safety, efficacy, and affordability of its products, making Medico Remedies a trusted name in the pharmaceutical industry.

Yash Optics & Lens Ltd

The market cap of Medico Remedies Ltd stands at Rs. 220.29 crore. Its monthly return is -5.83%, while the one-year return is -4.05%. Currently, the stock is 6.24% away from its 52-week high.

Yash Optics & Lens Ltd is renowned for its precision in crafting high-quality optical lenses. The company leverages advanced technology to produce lenses that enhance vision clarity and comfort for users worldwide.

Their commitment to innovation extends to developing progressive and specialized lenses that meet diverse consumer needs. Yash Optics & Lens Ltd continues to push the boundaries of optical science, ensuring their products lead in both performance and reliability.

Nectar Lifesciences Ltd

The market cap of Nectar Lifesciences Ltd is Rs. 765.85 crore. Its monthly return stands at 4.65%, while the one-year return is 96.26%. Presently, the stock is 33.82% away from its 52-week high.

Nectar Lifesciences Ltd is a prominent pharmaceutical company that excels in manufacturing a wide range of active pharmaceutical ingredients (APIs) and finished dosage forms. The company’s global reach extends to over 75 countries, emphasizing its role in international healthcare.

Focused on innovation and quality, Nectar Lifesciences invests substantially in research and development. This strategic approach ensures that they remain at the forefront of pharmaceutical advancements, continuously improving the efficacy and safety of their products.

List Of Best Pharma Penny Stocks Under Rs. 100 – PE Ratio

ZIM Laboratories Ltd

The market cap of ZIM Laboratories Ltd stands at Rs. 474.59 crore. Its monthly return is -4.20%, while the one-year return is 20.88%. Currently, the stock is 59.39% away from its 52-week high.

ZIM Laboratories Ltd stands out in the pharmaceutical industry for its expertise in innovative drug delivery solutions. The company specializes in developing and manufacturing complex generics that enhance patient compliance and efficacy.

Their commitment to cutting-edge research drives the development of novel formulations and technologies. ZIM Laboratories Ltd prioritizes patient-centric products, which has solidified its reputation as a leader in pharmaceutical innovation and quality.

Cian Healthcare Ltd

The market cap of Cian Healthcare Ltd is Rs. 54.57 crore. Its monthly return stands at -6.16%, while the one-year return is -12.84%. Presently, the stock is 88.62% away from its 52-week high.

Cian Healthcare Ltd is a dynamic pharmaceutical company that specializes in the formulation and marketing of a diverse range of healthcare products. With a strong emphasis on quality and innovation, Cian is dedicated to improving patient health and wellness.

The company operates state-of-the-art manufacturing facilities and adheres to strict quality control measures. This commitment ensures that Cian Healthcare Ltd consistently delivers safe and effective healthcare solutions to markets both in India and internationally.

Trade Intraday, Equity and Commodity in Alice Blue and Save 33.3% Brokerage.

Top 10 Pharma Penny Stocks Under Rs  100- FAQs

Which Are The Best Pharma Penny Stocks Under Rs 100?

Best Pharma Penny Stocks Under Rs 100 # 1: Alembic Ltd

Best Pharma Penny Stocks Under Rs 100 # 2: Morepen Laboratories Ltd

Best Pharma Penny Stocks Under Rs 100 # 3: Syncom Formulations (India) Ltd

Best Pharma Penny Stocks Under Rs 100 # 4: Nectar Lifesciences Ltd

Best Pharma Penny Stocks Under Rs 100 # 5: ZIM Laboratories Ltd

The Best Pharma Penny Stocks Under Rs 100 are based on market capitalization.

What Are The Top Pharma Penny Stocks Under Rs 100?

Based on the one-year return, The Top Pharma Penny Stocks Under Rs 100 are Pharmaids Pharmaceuticals Ltd, Gennex Laboratories Ltd, Ind Swift Ltd, Ambalal Sarabhai Enterprises Ltd, and Syncom Formulations (India) Ltd.

Can I Invest In Pharma Penny Stocks Under Rs 100?

Yes, you can invest in pharma penny stocks under Rs 100, but it involves high risk. Thorough research and a clear understanding of the risks associated with such speculative investments are essential.

Is It Good To Invest In Pharma Penny Stocks Under Rs 100?

Investing in pharma penny stocks under Rs 100 can be profitable but is highly risky. It suits investors who are comfortable with potential high volatility and the possibility of significant financial losses.

How To Invest In Pharma Penny Stocks Under Rs 100?

To invest in pharma penny stocks under Rs 100, research thoroughly, choose a reputable brokerage, monitor the pharmaceutical industry closely, and diversify your investments to mitigate risks.

Here are some of the Best Stock Research Articles listed based on Top Sectors (Industries), Market Cap, and Fundamental Analysis Factors:

Shares Below 5Long term penny stocksNifty ITDebt Free
Companies
Mid Cap Stocks
Shares Below 50High Volume Penny StocksNifty FMCGBest Debt Free Stocks under Rs 1000List Of Mid Cap Stocks In Nse
Shares Below 1Agriculture Penny Stocks In IndiaNifty MetalDebt Free Stocks Under 5Best Mid Cap Stocks Under 100 Rs
Best Shares Below 1000Best NBFC Penny Stocks In IndiaBse FMCGLong Term StocksMidcap Stocks under 50
Best share under 30 rsHighest dividend Paying Penny StocksBSE HealthcareBest Short Term StocksMidcap Stocks under 500
Top Stocks Under Rs 2000EV Stocks in IndiaBSE Metal Stocks listBest mutual fund in india for long termMid cap stocks in BSE
Pharma Stocks Below 1000Logistic Stocks IndiaBSE Midcap Stocks ListBest Dividend Yield FundLarge Cap Stocks
Real Estate Stocks Below 100Jewelry StocksHigh-beta StocksBest Target Maturity FundLarge Cap Stocks List In Nse
Real Estate Stocks Below 500Best Cement StocksMonopoly StocksBest Value FundLarge cap stocks under 100
Logistics Stocks Below 50Housing stocksLower Circuit StocksBest Mutual Fund For Short Term For 6 MonthsLarge cap stocks under 200
Logistics Stocks Below 500Infrastructure StocksUpper Circuit StocksTop 10 Low Risk Mutual Funds for SIPLarge cap stocks under 500
Packaging Stocks Below 500Semiconductor Stocks In IndiaConstruction & Engineering Stocks With High Dividend YieldSmall Cap CompaniesLarge cap stocks in BSE
Paper Stocks Below 500Asset management company stocks in indiaConsumer Finance Stocks With High Dividend YieldSmall Cap Stocks 100List Of Kalyani Stocks
Pharma Penny stocks under Rs 100Biotechnology StocksPharma Stocks With High Dividend YieldSmall Cap Stocks Under 500 RsList of Kirloskar Stocks
Pharma Stocks Below 200Finnifty Stocks ListDebt Free Stocks Under 20Small Cap Green Energy StocksMahindra & Mahindra Group Stocks
Pharma Stocks Below 500Nifty RealtyDebt Free Stocks Under 200 RsSmall cap stocks in BSEPiramal Ajay Group Stocks
Penny Pharma stocksLow PE stocks in Nifty 50Debt Free Stocks Below 100Small Cap Healthcare StocksChidambaram Group Stocks

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Leave a Reply

Your email address will not be published. Required fields are marked *

All Topics
Related Posts
Hospital Stocks With High Dividend Yield
Finance

Hospital Stocks With High Dividend Yield

The table below shows the Hospital Stocks With High Dividend Yield based on the Highest Market Capitalization. Name Market Cap (Cr) Close Price Dividend Yield